Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4341)
All Articles published online
|
Oct 31, 2009 (publication date) through Nov 4, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ishikawa T. Future perspectives on the treatment of hepatocellular carcinoma with cisplatin. World J Hepatol 2009; 1(1): 8-16 [PMID: 21160960 DOI: 10.4254/wjh.v1.i1.8] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v1/i1/8.htm |
| Number | Citing Articles |
| 1 |
Toru Ishikawa. Treatment Strategy for Recurrent Multiple Hepatocellular Carcinoma. Journal of Cancer Therapy 2013; 4(02): 408 doi: 10.4236/jct.2013.42A049
|
| 2 |
Eucalyptol Protects against Cisplatin-Induced Liver Injury in Rats. Biology Bulletin 2023; 50(5): 987 doi: 10.1134/S106235902360085X
|
| 3 |
Jean-Philippe Guégan, Frédéric Ezan, Nathalie Théret, Sophie Langouët, Georges Baffet. MAPK signaling in cisplatin-induced death: predominant role of ERK1 over ERK2 in human hepatocellular carcinoma cells. Carcinogenesis 2013; 34(1): 38 doi: 10.1093/carcin/bgs317
|
| 4 |
Hiroki Nishikawa, Yukio Osaki, Ryuichi Kita, Toru Kimura. Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma in Japan. Cancers 2012; 4(1): 165 doi: 10.3390/cancers4010165
|
| 5 |
HIROKI NISHIKAWA, YUKIO OSAKI, ERIKO IGUCHI, HARUHIKO TAKEDA, JUN NAKAJIMA, FUMIHIRO MATSUDA, AZUSA SAKAMOTO, SHINICHIRO HENMI, KEIICHI HATAMARU, SUMIO SAITO, AKIHIRO NASU, RYUICHI KITA, TORU KIMURA. Comparison of the efficacy of transcatheter arterial chemoembolization and sorafenib for advanced hepatocellular carcinoma. Experimental and Therapeutic Medicine 2012; 4(3): 381 doi: 10.3892/etm.2012.611
|
| 6 |
Wei Wang, Jianwen Cheng, Jiang-Jiang Qin, Sukesh Voruganti, Subhasree Nag, Jia Fan, Qiang Gao, Ruiwen Zhang. RYBP expression is associated with better survival of patients with hepatocellular carcinoma (HCC) and responsiveness to chemotherapy of HCC cells in vitro and in vivo. Oncotarget 2014; 5(22): 11604 doi: 10.18632/oncotarget.2598
|
| 7 |
Mayada M. El-Gizawy, Eman N. Hosny, Hagar H. Mourad, Amira N. Abd-El Razik. Curcumin nanoparticles ameliorate hepatotoxicity and nephrotoxicity induced by cisplatin in rats. Naunyn-Schmiedeberg's Archives of Pharmacology 2020; 393(10): 1941 doi: 10.1007/s00210-020-01888-0
|
| 8 |
Aleyna Atik, Tuğçe Günal, Pınar Acar Bozkurt, Sıla Naz Köse, Burcak Alp, Cihangir Yandım, Nurettin Mete Kaleli, Gözde Kabay, Gizem Kaleli-Can. Characterization of cisplatin loaded hydrophilic glycol chitosan modified eumelanin nanoparticles for potential controlled-release application. Journal of Drug Delivery Science and Technology 2023; 84: 104440 doi: 10.1016/j.jddst.2023.104440
|
| 9 |
Enas Tahoun, Gamalat Elgedawy, Amanallah El-Bahrawy. Cytoprotective effect of ginger extract on cisplatin-induced hepatorenal toxicity in rats via modulation of oxidative stress, inflammation and apoptosis: histopathological, biochemical and immunohistochemical study. Comparative Clinical Pathology 2021; 30(4): 647 doi: 10.1007/s00580-021-03256-7
|
| 10 |
Alina-Veronica Ghionescu, Andrei Sorop, Simona Olimpia Dima. The pivotal role of EMT-related noncoding RNAs regulatory axes in hepatocellular carcinoma. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1270425
|
| 11 |
Kohei Ogawa, Kenya Kamimura, Yukari Watanabe, Yosuke Motai, Daisuke Kumaki, Ryoya Seki, Akira Sakamaki, Satoshi Abe, Hirokazu Kawai, Takeshi Suda, Satoshi Yamagiwa, Shuji Terai. Effect of double platinum agents, combination of miriplatin-transarterial oily chemoembolization and cisplatin-hepatic arterial infusion chemotherapy, in patients with hepatocellular carcinoma: Report of two cases. World Journal of Clinical Cases 2017; 5(6): 238-246 doi: 10.12998/wjcc.v5.i6.238
|
| 12 |
Masafumi Ikeda, Takuji Okusaka, Yozo Sato, Junji Furuse, Shuichi Mitsunaga, Hideki Ueno, Chigusa Morizane, Yoshitaka Inaba, Tatsushi Kobayashi, Yasuaki Arai. A Phase I/II trial of continuous hepatic intra-arterial infusion of 5-fluorouracil, mitoxantrone and cisplatin for advanced hepatocellular carcinoma. Japanese Journal of Clinical Oncology 2017; 47(6): 512 doi: 10.1093/jjco/hyx038
|
| 13 |
Cheng-Jeng Tai, Wen-Ching Wang, Chien-Kai Wang, Chih-Hsiung Wu, Mei-Due Yang, Yu-Jia Chang, Jiun-Yu Jian, Chen-Jei Tai. Fermented Wheat Germ Extract Induced Cell Death and Enhanced Cytotoxicity of Cisplatin and 5-Fluorouracil on Human Hepatocellular Carcinoma Cells. Evidence-Based Complementary and Alternative Medicine 2013; 2013: 1 doi: 10.1155/2013/121725
|
| 14 |
Koichi Hamada, Shigeki Imai, Satoshi Saitoh. Safety and efficacy of transcatheter arterial chemoembolization using miriplatin and cisplatin (double platinum-lipiodol suspension) for hepatocellular carcinoma. Kanzo 2014; 55(3): 189 doi: 10.2957/kanzo.55.189
|
| 15 |
Mahendra Pal Singh, Hee Jun Cho, Jong-Tae Kim, Kyoung Eun Baek, Hee Gu Lee, Sun Chul Kang. Morin Hydrate Reverses Cisplatin Resistance by Impairing PARP1/HMGB1-Dependent Autophagy in Hepatocellular Carcinoma. Cancers 2019; 11(7): 986 doi: 10.3390/cancers11070986
|
| 16 |
Dan Li, Xuefeng Liu, Jian Zhou, Jie Hu, Dongdong Zhang, Jing Liu, Yanyan Qiao, Qimin Zhan. Long noncoding RNA HULC modulates the phosphorylation of YB‐1 through serving as a scaffold of extracellular signal–regulated kinase and YB‐1 to enhance hepatocarcinogenesis. Hepatology 2017; 65(5): 1612 doi: 10.1002/hep.29010
|
| 17 |
Jesmin Mondal, Anisur Rahman Khuda-Bukhsh. Cisplatin and farnesol co-encapsulated PLGA nano-particles demonstrate enhanced anti-cancer potential against hepatocellular carcinoma cells in vitro. Molecular Biology Reports 2020; 47(5): 3615 doi: 10.1007/s11033-020-05455-x
|
| 18 |
Jun Gao, Chao Dai, Xin Yu, Xiang‐Bao Yin, Fan Zhou. Long noncoding RNA LEF1‐AS1 acts as a microRNA‐10a‐5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway. Journal of Cellular Biochemistry 2021; 122(1): 86 doi: 10.1002/jcb.29833
|
| 19 |
Moumita Maji, Indira Bhattacharya, Sourav Acharya, Manas Pratim Chakraborty, Arnab Gupta, Arindam Mukherjee. Hypoxia Active Platinum(IV) Prodrugs of Orotic Acid Selective to Liver Cancer Cells. Inorganic Chemistry 2021; 60(7): 4342 doi: 10.1021/acs.inorgchem.0c03803
|
| 20 |
HIROKI NISHIKAWA, YUKIO OSAKI, RYUICHI KITA, TORU KIMURA, YOSHIAKI OHARA, HARUHIKO TAKEDA, AZUSA SAKAMOTO, SUMIO SAITO, NORIHIRO NISHIJIMA, AKIHIRO NASU, HIDEYUKI KOMEKADO, SHUHEI NISHIGUCHI. Comparison of transcatheter arterial chemoembolization and transcatheter arterial chemotherapy infusion for patients with intermediate-stage hepatocellular carcinoma. Oncology Reports 2014; 31(1): 65 doi: 10.3892/or.2013.2845
|
| 21 |
Shogo Ohkoshi. Interferon- β Augments the Effects of Cisplatin on Hcc Cell Lines by Regulating Sub Cellular Localization of P21. Gastroenterology & Hepatology: Open Access 2015; 3(3) doi: 10.15406/ghoa.2015.03.00079
|
| 22 |
Gang Li, Xin Li, Iqbal Mahmud, Jazmin Ysaguirre, Baharan Fekry, Shuyue Wang, Bo Wei, Kristin L. Eckel-Mahan, Philip L. Lorenzi, Richard Lehner, Kai Sun. Interfering with lipid metabolism through targeting CES1 sensitizes hepatocellular carcinoma for chemotherapy. JCI Insight 2023; 8(2) doi: 10.1172/jci.insight.163624
|
| 23 |
Qunying Zhuang, Tengjian Zhou, Chengyong He, Shili Zhang, Yang Qiu, Bing Luo, Ran Zhao, Hengchuan Liu, Yuchun Lin, Zhongning Lin. Protein phosphatase 2A-B55δ enhances chemotherapy sensitivity of human hepatocellular carcinoma under the regulation of microRNA-133b. Journal of Experimental & Clinical Cancer Research 2016; 35(1) doi: 10.1186/s13046-016-0341-z
|
| 24 |
Masanori Ozaki, Ken Kageyama, Kenjiro Kimura, Shinpei Eguchi, Akira Yamamoto, Ryota Tanaka, Takehito Nota, Hiroki Yonezawa, Hideyuki Nishiofuku, Yuki Sakai, Naoki Tani, Atsushi Jogo, Mizue Terai, Takami Sato, Takeaki Ishizawa, Yukio Miki. A rat-based preclinical platform facilitating transcatheter hepatic arterial infusion in immunodeficient rats with liver xenografts of patient-derived pancreatic ductal adenocarcinoma. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-61142-y
|
| 25 |
Enas E. Eltamany, Sameh S. Elhady, Mohamed S. Nafie, Haidy A. Ahmed, Dina M. Abo-Elmatty, Safwat A. Ahmed, Jihan M. Badr, Asmaa R. Abdel-Hamed. The Antioxidant Carrichtera annua DC. Ethanolic Extract Counteracts Cisplatin Triggered Hepatic and Renal Toxicities. Antioxidants 2021; 10(6): 825 doi: 10.3390/antiox10060825
|
| 26 |
Fotini Papachristou, Nikolia Anninou, Georgios Koukoulis, Stefanos Paraskakis, Eleni Sertaridou, Christos Tsalikidis, Michael Pitiakoudis, Constantinos Simopoulos, Alexandra Tsaroucha. Differential effects of cisplatin combined with the flavonoid apigenin on HepG2, Hep3B, and Huh7 liver cancer cell lines. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 2021; 866: 503352 doi: 10.1016/j.mrgentox.2021.503352
|
| 27 |
Liang-Tzung Lin, Chen-Jei Tai, Ching-Hua Su, Fang-Mo Chang, Chen-Yen Choong, Chien-Kai Wang, Cheng-Jeng Tai. The Ethanolic Extract ofTaiwanofungus camphoratus(Antrodia camphorata) Induces Cell Cycle Arrest and Enhances Cytotoxicity of Cisplatin and Doxorubicin on Human Hepatocellular Carcinoma Cells. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/415269
|
| 28 |
Hao Zhang, Qiao-Ling Yu, Lin Meng, Hong Huang, Hui Liu, Na Zhang, Na Liu, Jun Yang, Yuan-Zhen Zhang, Qiang Huang. TAZ-regulated expression of IL-8 is involved in chemoresistance of hepatocellular carcinoma cells. Archives of Biochemistry and Biophysics 2020; 693: 108571 doi: 10.1016/j.abb.2020.108571
|
| 29 |
Dipak D. Meshram, Claire V.S. Pike, Peter J. Coussons. Inhibition of Transglutaminase 2 activity increases cisplatin cytotoxicity in a model of human hepatocarcinoma chemotherapy. European Journal of Pharmacology 2017; 815: 332 doi: 10.1016/j.ejphar.2017.09.035
|
| 30 |
Dandan Zhao, Hongyan Zhen, Jian Xue, Zhipeng Tang, Xiaofang Han, Zhanfen Chen. A novel benzothiazole-based mononuclear platinum(II) complex displaying potent antiproliferative activity in HepG-2 cells via mitochondrial-mediated apoptosis. Journal of Inorganic Biochemistry 2024; 251: 112437 doi: 10.1016/j.jinorgbio.2023.112437
|
| 31 |
Kenya Kamimura, Takeshi Suda, Takeshi Yokoo, Hiroteru Kamimura, Tsutomu Kanefuji, Atsunori Tsuchiya, Masaaki Takamura, Hirokazu Kawai, Nobuo Waguri, Satoshi Yamagiwa, Shuji Terai. Transhepatic arterial infusion chemotherapy using a combination of miriplatin and CDDP powder versus miriplatin alone in the treatment of hepatocellular carcinoma: a randomized controlled trial. BMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3320-7
|
| 32 |
Kenya Kamimura, Takeshi Suda, Yasushi Tamura, Masaaki Takamura, Takeshi Yokoo, Masato Igarashi, Hirokazu Kawai, Satoshi Yamagiwa, Minoru Nomoto, Yutaka Aoyagi. Phase I study of miriplatin combined with transarterial chemotherapy using CDDP powder in patients with hepatocellular carcinoma. BMC Gastroenterology 2012; 12(1) doi: 10.1186/1471-230X-12-127
|
| 33 |
Toru Ishikawa, Kazuo Higuchi, Tomoyuki Kubota, Keiichi Seki, Terasu Honma, Toshiaki Yoshida, Tomoteru Kamimura. Prevention of intrahepatic distant recurrence by transcatheter arterial infusion chemotherapy with platinum agents for stage I/II hepatocellular carcinoma. Cancer 2011; 117(17): 4018 doi: 10.1002/cncr.25989
|